1 The aim of this pilot study was to investigate if the porphyrinuria produced by arsenic in rodents was present in humans chronically exposed to arsenic via drinking water.
2 The concentrations of uroporphyrin, coproporphyrin and total arsenic in urine were compared between 21 individuals exposed to arsenic in their drinking water (0.390 mg 1-1) and 19 controls exposed to 0.012 mg 1-1.
3 Arsenic-exposed individuals had significantly higher total arsenic concentrations in their urine than the control group. No increase in urinary porphyrin excretion was found in exposed individuals. However, an inversion of the coproporphyrin/uroporphyrin (COPRO/ URO) ratio was observed in most exposed individuals. This inversion was caused both, by a decrease in coproporphyrin excretion and an increase in uroporphyrin excretion.
4 No demonstrable correlations between porphyrin excretion, the COPRO/URO ratio and total arsenic concentration in urine were found in exposed individuals.
Get full access to this article
View all access options for this article.
References
1.
Tseng WP, Chu HM, Fong JM, Ling CS & Yeh S.Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan . Journal of the National Cancer Institute1968; 40: 453-63.
2.
Feinglass EJArsenic intoxication from well water in the U.SNew England Journal of Medicine1973; 228: 828-30.
3.
Grantham SA & Jones JFArsenic contamination of water wells in Nova Scotia. Journal of the American Water Works Association1977; 69: 653-7.
4.
Astolfi E.Estudio de arsenicismo en agua de consumo. La Prensa Médica Argentina1971; 58: 1342-3.
5.
Cebrian ME, Albores A., Aguilar M. & Blakely E.Chronic arsenic poisoning in the North of Mexico. Human Toxicology1983; 2: 121-33.
6.
Thompson Rhs.The reactions of arsenicals in living tissues . Biochemistry Society Symposium1948; 2: 28-38.
7.
Webb JLEnzyme and Metabolic Inhibitors, Vol. 3, p. 595. New York : Academic Press, 1966.
8.
Marks GSExposure to toxic agents: the heme biosynthetic pathway and hemoproteins as indicator. CRC Critical Reviews in Toxicology1985; 15: 151-79.
9.
Woods JS & Fowler BAEffects of chronic arsenic exposure on hematopoietic function in adult mammalian liver. Environmental Health Perspectives1977 ; 19: 209-13.
10.
Woods JS & Fowler BAAltered regulation of mammalian hepatic heme biosynthesis and urinary porphyrin excretion during prolonged exposure to sodium arsenate. Toxicology and Applied Pharmacology1978; 43: 361-71.
11.
Martinez G. , Cebrian M., Chamorro G. & Jauge P.Urinary uroporphyrin as an indicator of arsenic exposure in rats. Proceedings of the Western Pharmacology Society1983; 26: 171-4.
12.
Cebrian ME, Albores A., Connolly JC & Bridges JWAssessment of arsenic effects on cytosolic heme status using tryptophan pyrrolase as an index. Journal of Biochemistry Toxicology1988; 3: 77-86.
13.
Fernandez AA & Jacobs SLStandard Methods of Clinical Chemistry, ed. R.P. MacDonald, Vol 6, p. 57. New York: Academic Press, 1970.
14.
Fuhrhop JHLaboratory Methods in Porphyrin and Metalloporphyrins Research, eds. J.H. Fuhrhop & K.M. Smith , p. 22. Amsterdam: Elsevier Scientific Publishing. 1975.
15.
Strik Jjtwa, Doss M., Schraa G., et al. Coproporphyrinuria and chronic hepatic porphyria type A found in farm families from Michigan (U.S.A.) exposed to polybrominated biphenyls (PBB). In: Chemical Porphyria in Man, eds JJTWA Strik & J.H. Koeman, p. 29. Amsterdam: Elsevier/North-Holland Biomedical Press , 1979.
16.
Bousnes RW & Tawssky HHOn the colorimetric determination of creatinine by the Jaffe reaction. Journal of Biological Chemistry1945; 158: 581-4.
17.
Cox DHArsine evolution-electrothermal atomic absorption method for the determination of nanogram levels of total arsenic in urine and water. Journal of AnalyticalToxicology1980; 4: 207-11.
18.
World Health Organization (WHO).Environmental Health Criteria: Arsenic, Vol. 19, EHE/EHC/. Geneve: WHO, 1981.
19.
Strik Jjtwa.Porphyrins in urine as an indication of exposure to chlorinated hydrocarbons . In: Mechanisms of Chemical-Induced Porphyrinopaties, eds Ellen K. Silbergeld & Bruce A. Fowler.Annals of The New York Academy of Sciences, Vol. 514, p. 219. New York: The New York Academy of Sciences, 1987.
20.
Doss M.Chronic hepatic porphyrias in humans (endogenic factors). In: Chemical Porphyria in Man, eds. J.J.T.W.A. Strik & J.H. Koeman, p. 11. Amsterdam: Elsevier/North-Holland Biomedical Press, 1979.
21.
Woods JS, Kardish RM & Fowler BAStudies on the action of porphyrinogenic trace metals on the activity of hepatic uroporphyrinogen decarboxilase. Biochemical and Biophysical Research Communications1981; 103: 264-71.
22.
Woods JS & Fowler BAMetal alteration of uroporphyrinogen decarboxilase and coproporphyrinogen oxidase. In: Mechanisms of Chemical-Induced Porphyrinopaties , eds. Ellen K. Silbergeld & Bruce A. Fowler.Annals of The New York Academy of Sciences. Vol. 514. p. 55. New York: The New York Academy of Sciences, 1987.
